[go: up one dir, main page]

NO20083117L - Antitumor sammensetninger - Google Patents

Antitumor sammensetninger

Info

Publication number
NO20083117L
NO20083117L NO20083117A NO20083117A NO20083117L NO 20083117 L NO20083117 L NO 20083117L NO 20083117 A NO20083117 A NO 20083117A NO 20083117 A NO20083117 A NO 20083117A NO 20083117 L NO20083117 L NO 20083117L
Authority
NO
Norway
Prior art keywords
compositions
derivatives
tumor compositions
theonellidae
swinhoei
Prior art date
Application number
NO20083117A
Other languages
English (en)
Norwegian (no)
Inventor
Maria Del Carmen Cuevas Marchante
Ma Jesus Martin Lopez
Andres Francesch Solloso
Jose Fernando Reyes Benitez
Rogelio Fernandes Rodriguez
Laura Coello Molinero
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Publication of NO20083117L publication Critical patent/NO20083117L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D323/00—Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
NO20083117A 2005-12-15 2008-07-14 Antitumor sammensetninger NO20083117L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200503092A ES2276629B1 (es) 2005-12-15 2005-12-15 Compuestos antitumorales.
PCT/ES2006/000687 WO2007068776A1 (fr) 2005-12-15 2006-12-14 Composes antitumoraux

Publications (1)

Publication Number Publication Date
NO20083117L true NO20083117L (no) 2008-08-08

Family

ID=38162592

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083117A NO20083117L (no) 2005-12-15 2008-07-14 Antitumor sammensetninger

Country Status (13)

Country Link
US (1) US20090030068A1 (fr)
EP (1) EP1972633A1 (fr)
JP (1) JP2009519301A (fr)
KR (1) KR20080075911A (fr)
CN (1) CN101331137A (fr)
AU (1) AU2006325165A1 (fr)
CA (1) CA2633543A1 (fr)
ES (1) ES2276629B1 (fr)
IL (1) IL192045A0 (fr)
NO (1) NO20083117L (fr)
NZ (1) NZ569194A (fr)
RU (1) RU2428425C2 (fr)
WO (1) WO2007068776A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2321325A1 (fr) * 2008-07-03 2011-05-18 Pharma Mar S.A. Macrolides antitumoraux
WO2013023287A1 (fr) * 2011-08-16 2013-02-21 Destiny Software Productions Inc. Rendu vidéo basé sur un script
RU2655166C1 (ru) * 2017-04-18 2018-05-24 ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ УНИТАРНОЕ ПРЕДПРИЯТИЕ "ИНСТИТУТ ХИМИЧЕСКИХ РЕАКТИВОВ И ОСОБО ЧИСТЫХ ХИМИЧЕСКИХ ВЕЩЕСТВ НАЦИОНАЛЬНОГО ИССЛЕДОВАТЕЛЬСКОГО ЦЕНТРА "КУРЧАТОВСКИЙ ИНСТИТУТ" (НИЦ "Курчатовский институт - ИРЕА) Пиридинилметиленамино-бензо-18-крауны-6 и их медные комплексы
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
US11172322B2 (en) 2017-11-29 2021-11-09 GuRu Wireless, Inc. Wireless access authentication based on user location

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859782A (en) * 1986-06-26 1989-08-22 Harbor Branch Oceanographic Institution, Inc. Misakinolide compositions and their derivatives
GB9801741D0 (en) * 1998-01-27 1998-03-25 Inst Biomar Sa New cytotoxic tris (oxazole)-containing macrolides

Also Published As

Publication number Publication date
AU2006325165A1 (en) 2007-06-21
JP2009519301A (ja) 2009-05-14
IL192045A0 (en) 2008-12-29
RU2008128816A (ru) 2010-01-20
RU2428425C2 (ru) 2011-09-10
ES2276629A1 (es) 2007-06-16
US20090030068A1 (en) 2009-01-29
NZ569194A (en) 2010-09-30
ES2276629B1 (es) 2009-04-01
WO2007068776A1 (fr) 2007-06-21
CN101331137A (zh) 2008-12-24
CA2633543A1 (fr) 2007-06-21
EP1972633A1 (fr) 2008-09-24
KR20080075911A (ko) 2008-08-19
WO2007068776B1 (fr) 2007-08-02

Similar Documents

Publication Publication Date Title
NO20083267L (no) Azaindole inhibitorer av aurora kinaser
MX2009012168A (es) Derivados de pirrolopiridina y su uso como inhibidores de la enzima que escinde la proteina precursora de amiloide por el sitio beta.
TW200734311A (en) New compounds
NO20076196L (no) Nye 2-azetidinonderivater som kolesterolabsorpsjonsinhibitorer for behandling av hyperlipidemiske tilstander
GEP20146003B (en) Benzothiazole derivatives as anticancer agents
WO2010108074A3 (fr) Inhibiteurs de pi3 kinase
MX2011011335A (es) Inhibidores de fosfoinositida 3 cinasa y/u objetivo mamifero de rapamicina.
NO20076195L (no) Nye 2-azetidinonderivater for behandling av hyperlipidemiske sykdommer
NO20090755L (no) Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens
WO2009155121A3 (fr) Inhibiteurs de la pi3 kinase
NO20090166L (no) Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens
NO20076197L (no) Nye 2-azetidinonderivater anvendbare i behandling av hyperlipidemiske tilstander
GEP20146146B (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
TW200833675A (en) Nicotinamide derivatives
NO20081454L (no) Met-kinaseinhibitorer
NO20075299L (no) Hydrogenated benzo (c) thiophene derivatives as immunomodulators
NO20090025L (no) Pyrrolotriazinkinaseinhibitorer
NO20082709L (no) Kjemiske forbindelser
JO2910B1 (en) Organic compounds
NO20075113L (no) Proteinkinaseinhibitorer
WO2007048070A3 (fr) Composés et méthodes d'utilisation
WO2010150211A3 (fr) Utilisation de dérivés d'indoles dans le traitement du cancer
TN2010000038A1 (en) Organic compounds
NO20092035L (no) Tiazolylforbindelser anvendbare som kinaseinhibitorer
NO20073170L (no) Kaspaseinhibitorer og anvendelse derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application